|
1
|
Gerratana L, Fanotto V, Bonotto M,
Bolzonello S, Minisini AM, Fasola G and Puglisi F: Pattern of
metastasis and outcome in patients with breast cancer. Clin Exp
Metastasis. 32:125–133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bonotto M, Gerratana L, Poletto E, Driol
P, Giangreco M, Russo S, Minisini AM, Andreetta C, Mansutti M, Pisa
FE, et al: Measures of outcome in metastatic breast cancer:
Insights from a real-world scenario. Oncologist. 19:608–615. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bale R, Putzer D and Schullian P: Local
treatment of breast cancer liver metastasis. Cancers (Basel).
11:1–15. 2019. View Article : Google Scholar
|
|
4
|
Jung SY, Sereika SM, Linkov F, Brufsky A,
Weissfeld JL and Rosenzweig M: The effect of delays in treatment
for breast cancer metastasis on survival. Breast Cancer Res Treat.
130:953–964. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma R, Feng Y, Lin S, Chen J, Lin H, Liang
X, Zheng H and Cai X: Mechanisms involved in breast cancer liver
metastasis. J Transl Med. 13:642015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoo B, Kavishwar A, Wang P, Ross A,
Pantazopoulos P, Dudley M, Moore A and Medarova Z: Therapy targeted
to the metastatic niche is effective in a model of stage IV breast
cancer. Sci Rep. 7:450602017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Echeverria GV, Powell E, Seth S, Ge Z,
Carugo A, Bristow C, Peoples M, Robinson F, Qiu H, Shao J, et al:
High-resolution clonal mapping of multi-organ metastasis in triple
negative breast cancer. Nat Commun. 9:50792018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Verma S, Kalita B, Bajaj S, Prakash H,
Singh AK and Gupta ML: A combination of podophyllotoxin and rutin
alleviates radiation-induced pneumonitis and fibrosis through
modulation of lung inflammation in mice. Front Immunol. 8:658–672.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kimbung S, Loman N and Hedenfalk I:
Clinical and molecular complexity of breast cancer metastases.
Semin Cancer Biol. 35:85–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu ZJ, Semenza GL and Zhang HF:
Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang
Univ Sci B. 16:32–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Insua-Rodríguez J and Oskarsson T: The
extracellular matrix in breast cancer. Adv Drug Deliv Rev.
97:41–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Obeid E, Nanda R, Fu YX and Olopade OI:
The role of tumor-associated macrophages in breast cancer
progression (review). Int J Oncol. 43:5–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Irshad S, Flores-Borja F, Lawler K,
Monypenny J, Evans R, Male V, Gordon P, Cheung A, Gazinska P, Noor
F, et al: RORγt+ innate lymphoid cells promote lymph node
metastasis breast cancers. Cancer Res. 77:1083–1096. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Silva S, Danson S, Teare D, Taylor F,
Bradford J, McDonagh AJG, Salawu A, Wells G, Burghel GJ, Brock I,
et al: Genome-wide analysis of circulating cell-free DNA copy
number detects active melanoma and predicts survival. Clin Chem.
64:1338–1346. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao Y, Ni X, Guo H, Su Z, Ba Y, Tong Z,
Guo Z, Yao X, Chen X, Yin J, et al: Single-cell sequencing
deciphers a convergent evolution of copy number alterations from
primary to circulating tumor cells. Genome Res. 27:1312–1322. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Poell JB, Mendeville M, Sie D, Brink A,
Brakenhoff RH and Ylstra B: ACE: Absolute copy number estimation
from low-coverage whole-genome sequencing data. Bioinformatics.
35:2847–2849. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao YB, Zhang B and Wu YL: Radiofrequency
ablation versus hepatic resection for breast cancer liver
metastasis: A systematic review and meta-analysis. J Zhejiang Univ
Sci B. 19:829–843. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Treska V, Cerna M, Kydlicek T and Treskova
I: Prognostic factors of breast cancer liver metastasis surgery.
Arch Med Sci. 11:683–685. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mego M, Karaba M, Minarik G, Benca J,
Silvia J, Sedlackova T, Manasova D, Kalavska K, Pindak D,
Cristofanilli M, et al: Circulating tumor cells with
epithelial-to-mesenchymal transition phenotypes associated with
inferior outcomes in primary breast cancer. Anticancer Res.
39:1829–1837. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arkadius P, Volkmar M, Jens H, Wolfgang J
and Tanja F: Circulating tumor cells in metastatic breast cancer:
Clinical relevance and biological potential. Curr Opin Obstet
Gynecol. 31:76–81. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mansouri S, Mokhtari-Hesari P,
Naghavi-Al-Hosseini F, Majidzadeh-A K and Farahmand L: The
prognostic value of circulating tumor cells in primary breast
cancer prior to any systematic therapy: A systematic review. Curr
Stem Cell Res Ther. 14:519–529. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Loh J, Jovanovic L, Lehman M, Capp A,
Pryor D, Harris M, Nelson C and Martin J: Circulating tumor cell
detection in high-risk non-metastatic prostate cancer. J Cancer Res
Clin Oncol. 140:2157–2162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Liu Y, Zhang L, Tong L, Gao Y, Hu
F, Lin PP, Li B and Zhang T: Vimentin expression in circulating
tumor cells (CTCs) associated with liver metastases predicts poor
progression-free survival in patients with advanced lung cancer. J
Cancer Res Clin Oncol. 145:2911–2920. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duffy MJ, McDermott EW and Crown J:
Blood-based biomarkers in breast cancer: From proteins to
circulating tumor cells to circulating tumor DNA. Tumour Biol.
40:10104283187761692018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cristofanilli M, Pierga JY, Reuben J,
Rademaker A, Davis AA, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado
R, Mavroudis D, et al: The clinical use of circulating tumor cells
(CTCs) enumeration for staging of metastatic breast cancer (MBC):
International expert consensus paper. Crit Rev Oncol Hematol.
134:39–45. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bai L, Du Y, Peng J, Liu Y, Wang Y, Yang Y
and Wang C: Peptide-based isolation of circulating tumor cells by
magnetic nanoparticles. J Mater Chem B Mater Biol Med. 2:4080–4088.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bailey PC and Martin SS: Insights on CTC
biology and clinical impact emerging from advances in capture
technology. Cells. 8:5532019. View Article : Google Scholar
|
|
28
|
Imani S, Cheng J, Mobasher-Jannat A, Wei
C, Fu S, Yang L, Jadidi K, Khosravi MH, Mohazzab-Torabi S,
Shasaltaneh MD, et al: Identification of a novel RPGRIP1 mutation
in an Iranian family with leber congenital amaurosis by exome
sequencing. J Cell Mol Med. 22:1733–1742. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zong C, Lu S, Chapman AR and Xie XS:
Genome-wide detection of single-nucleotide and copy-number
variations of a single human cell. Science. 338:1622–1626. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Samur MK: RTCGAToolbox: A new tool for
exporting TCGA firehose data. PLoS One. 9:e1063972014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Silva GO, Siegel MB, Mose LE, Parker JS,
Sun W, Perou CM and Chen M: SynthEx: A synthetic-normal-based DNA
sequencing tool for copy number alteration detection and tumor
heterogeneity profiling. Genome Biol. 18:662017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Seiser EL and Innocenti F: Hidden markov
model-based CNV detection algorithms for illumina genotyping
microarrays. Cancer Inform. 13 (Suppl 7):77–83. 2015.PubMed/NCBI
|
|
34
|
Manzo A, Montanino A, Carillio G, Costanzo
R, Sandomenico C, Normanno N, Piccirillo MC, Daniele G, Perrone F,
Rocco G and Morabito A: Angiogenesis inhibitors in NSCLC. Int J Mol
Sci. 18:20212017. View Article : Google Scholar
|
|
35
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Liu J, Lu J, Peng J, Juan L, Zhu X,
Li B and Wang Y: Joint detection of copy number variations in
parent-offspring trios. Bioinformatics. 32:1130–1137. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lu X, Ye K, Zou K and Chen J:
Identification of copy number variation-driven genes for liver
cancer via bioinformatics analysis. Oncol Rep. 32:1845–1852. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Williams A, Balic M, Datar R and Cote R:
Size-based enrichment technologies for CTC detection and
characterization. Recent Results Cancer Res. 195:87–95. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Che J, Yu V, Garon EB, Goldman JW and Di
Carlo D: Biophysical isolation and identification of circulating
tumor cells. Lab Chip. 17:1452–1461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Krebs MG, Sloane R, Priest L, Lancashire
L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, Hughes A, Clack G,
et al: Evaluation and prognostic significance of circulating tumor
cells in patients with non-small-cell lung cancer. J Clin Oncol.
29:1556–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
van den Bos H, Bakker B, Spierings DCJ,
Lansdorp PM and Foijer F: Single-cell sequencing to quantify
genomic integrity in cancer. Int J Biochem Cell Biol. 94:146–150.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Khetrapal P, Lee MWL, Tan WS, Dong L, de
Winter P, Feber A and Kelly JD: The role of circulating tumour
cells and nucleic acids in blood for the detection of bladder
cancer: A systematic review. Cancer Treat Rev. 66:56–63. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Payne K, Brooks J, Spruce R, Batis N,
Taylor G, Nankivell P and Mehanna H: Circulating tumour cell
biomarkers in head and neck cancer: Current progress and future
prospects. Cancers (Basel). 11:11152019. View Article : Google Scholar
|
|
45
|
Ortiz V and Yu M: Analyzing circulating
tumor cells one at a time. Trends Cell Biol. 28:764–775. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu X, Wang J and Chen L: Whole-exome
sequencing reveals recurrent somatic mutation networks in cancer.
Cancer Lett. 340:270–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ren T, Suo J, Liu S, Wang S, Shu S, Xiang
Y and Lang JH: Using low-coverage whole genome sequencing technique
to analyze the chromosomal copy number alterations in the
exfoliative cells of cervical cancer. J Gynecol Oncol. 29:e782018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Brouwer A, De Laere B, Peeters D, Peeters
M, Salgado R, Dirix L and Van Laere S: Evaluation and consequences
of heterogeneity in the circulating tumor cell compartment.
Oncotarget. 7:48625–48643. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Huang W, Skanderup AJ and Lee CG: Advances
in genomic hepatocellular carcinoma research. Gigascience. 7:1–13.
2018. View Article : Google Scholar
|
|
50
|
Scatena R, Bottoni P and Giardina B:
Circulating tumour cells and cancer stem cells: A role for
proteomics in defining the interrelationships between function,
phenotype and differentiation with potential clinical applications.
Biochim Biophys Acta. 1835:129–143. 2013.PubMed/NCBI
|
|
51
|
Salvianti F and Pinzani P: The diagnostic
potential of mutation detection from single circulating tumor cells
in cancer patients. Expert Rev Mol Diagn. 17:975–981. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Salvianti F, Pazzagli M and Pinzani P:
Single circulating tumor cell sequencing as an advanced tool in
cancer management. Expert Rev Mol Diagn. 16:51–63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mohtar MA, Syafruddin SE, Nasir SN and Low
TY: Revisiting the roles of pro-metastatic EpCAM in cancer.
Biomolecules. 10:2552020. View Article : Google Scholar
|
|
54
|
de Wit S, van Dalum G, Lenferink AT, Tibbe
AG, Hiltermann TJ, Groen HJ, van Rijn CJ and Terstappen LW: The
detection of EpCAM(+) and EpCAM(−) circulating tumor cells. Sci
Rep. 5:122702015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Adams DL, Martin SS, Alpaugh RK,
Charpentier M, Tsai S, Bergan RC, Ogden IM, Catalona W, Chumsri S,
Tang CM and Cristofanilli M: Circulating giant macrophages as a
potential biomarker of solid tumors. Proc Natl Acad Sci USA.
111:3514–3519. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gires O and Stoecklein NH: Dynamic EpCAM
expression on circulating and disseminating tumor cells: Causes and
consequences. Cell Mol Life Sci. 71:4393–4402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Grover PK, Cummins AG, Price TJ,
Roberts-Thomson IC and Hardingham JE: Circulating tumour cells: The
evolving concept and the inadequacy of their enrichment by
EpCAM-based methodology for basic and clinical cancer research. Ann
Oncol. 25:1506–1516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Mikolajczyk SD, Millar LS, Tsinberg P,
Coutts SM, Zomorrodi M, Pham T, Bischoff FZ and Pircher TJ:
Detection of EpCAM-negative and cytokeratin-negative circulating
tumor cells in peripheral blood. J Oncol. 2011:2523612011.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yokobori T, Iinuma H, Shimamura T, Imoto
S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, et
al: Plastin3 is a novel marker for circulating tumor cells
undergoing the epithelial-mesenchymal transition and is associated
with colorectal cancer prognosis. Cancer Res. 73:2059–2069. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Auman JT and McLeod HL: Colorectal cancer
cell lines lack the molecular heterogeneity of clinical colorectal
tumors. Clin Colorectal Cancer. 9:40–47. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ghosh SK, McCormick TS and Weinberg A:
Human Beta defensins and cancer: Contradictions and common ground.
Front Oncol. 9:341–354. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Xu Z, Xu P, Fan W, Huang B, Cheng Q, Zhang
Z, Wang P and Yu M: The effect of an alternative chromosome 17
probe on fluorescence in situ hybridization for the assessment of
HER2 amplification in invasive breast cancer. Exp Ther Med.
18:2095–2103. 2019.PubMed/NCBI
|
|
63
|
Zubenko OS, Semeniuk DO, Starenka IO and
Pogribnyy PV: Effect of cytostatic agents on expression levels of
human beta-defensins-1-4 in A431 and MCF-7 cell lines. Exp Oncol.
40:79–81. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Shestakova T, Zhuravel E, Bolgova L,
Alekseenko O, Soldatkina M and Pogrebnoy P: Expression of human
beta-defensins-1, 2 and 4 mRNA in human lung tumor tissue: A pilot
study. Exp Oncol. 30:153–156. 2008.PubMed/NCBI
|
|
65
|
Joly S, Compton LM, Pujol C, Kurago ZB and
Guthmiller JM: Loss of human beta-defensin 1, 2, and 3 expression
in oral squamous cell carcinoma. Oral Microbiol Immunol.
24:353–360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Prahl A, Pazgier M, Alexandratos J and
Lubkowski J: Human β-defensin 4 - defensin without the ‘twist’.
Postepy Biochem. 62:349–361. 2016.PubMed/NCBI
|
|
67
|
Markeeva N, Lisovskiy I, Lyzogubov V,
Usenko V, Soldatkina M, Merentsev S, Zaitsev S, Kondratskii Y,
Tofan A, Osinskiy S, et al: Expression of beta-defensin-2 in human
gastric tumors: A pilot study. Exp Oncol. 27:30–135. 2005.
|
|
68
|
Kida-Takaoka S, Yamaai T, Mizukawa N,
Murakami J and Iida S: Surrounding cells affect the gene expression
pattern of human beta-defensins in squamous cell carcinoma in
vitro. Anticancer Res. 34:6443–6449. 2014.PubMed/NCBI
|
|
69
|
Winter J, Kraus D, Reckenbeil J and
Probstmeier R: Oncogenic relevant defensins: Expression pattern and
proliferation characteristics of human tumor cell lines. Tumour
Biol. 37:7959–7966. 2016. View Article : Google Scholar : PubMed/NCBI
|
